BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2300478
,
PDX1
,
Coagulation
,
Diabetes mellitus
,
Lung
,
Avian flu virus
,
Valproic acid
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
scavenger receptor class B, type I
Summary
General Info
Curated Studies
Most Correlated Studies
Colorectal cancer HCT116 cells p53 WT or null treated with nutlin-3A, entinostat, or both
Explore Curated Studies Results
Literature
Most Relevant Literature
SR-BI as a target of natural products and its significance in cancer.
RETRACTED: Deletion of the scavenger receptor Scarb1 in myeloid cells does not affect bone mass
Deficiency of SR-B1 reduced the tumor load of colitis-induced or APCmin /+ -induced colorectal cance…
High-Density Lipoprotein Therapy in Stroke: Evaluation of Endothelial SR-BI-Dependent Neuroprotectiv…
Elongated PEO-based nanoparticles bind the high-density lipoprotein (HDL) receptor scavenger recepto…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Effect of β-cryptoxanthin (β-Cx), Plant Sterols and Galactooligosaccharides on Systemic and Gastroin…
Genetic and Metabolism of Post-prandial HDL Particles
Safety and Efficacy Study of Pyridorin in Patients With Nephropathy Due to Type 2 Diabetes
SR-BI and Antiviral Treatment Response in HCV
Study of 3,5-Diiodothyropropionic Acid (DITPA) in Hypercholesterolemic Patients
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ